Unknown PHASE4 INTERVENTIONAL 2-arm NCT01168700

Trial of Supplementation With Aged Garlic Extract to Improve Endothelial Function in Patients With Metabolic Syndrome (Kymes)

A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF THE SUPPLEMENTATION WITH KIOLIC® IN PATIENTS WITH DIAGNOSIS OF METABOLIC SYNDROME TO IMPROVE ENDOTHELIAL FUNCTION AND INFLAMMATORY STATE. KYMES

Sponsor: Instituto de Salud de Bucaramanga

Conditions Metabolic Syndrome

Interventions Placebo aged garlic extract

Updated 4 times since 2017 Last updated: Jul 21, 2010 Started: Nov 30, 2009 Primary completion: Aug 31, 2010 Completion: Oct 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01168700, this PHASE4 trial focuses on Metabolic Syndrome and remains ongoing. Sponsored by Instituto de Salud de Bucaramanga, it has been updated 4 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jan 2017 — Jan 2021 [monthly]

Unknown Status PHASE4

First recorded

Nov 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Instituto de Salud de Bucaramanga
Universidad de Santander

Data source: Universidad de Santander

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bucaramanga, Colombia